{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:42:32Z","timestamp":1793652152714,"version":"4.5.1"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec id=\"ab-yoi230089-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Knowledge about characteristics of US pregnancy-associated decedents is needed to guide responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine individual sociodemographic characteristics and residing county\u2019s health care resources and socioeconomic factors among pregnancy-associated overdose decedents in comparison with obstetric decedents and overdose decedents who were not pregnant in the past year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cross-sectional, exploratory study included 1457 pregnant and postpartum overdose decedents, 4796 obstetric decedents, and 11\u202f205 nonpregnant overdose decedents aged 10 to 44 years from 2018 to 2021. Data were analyzed August 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Decedents from the 2018-2021 Multiple Cause of Death Files linked to the 2021 Area Health Resources Files and the 2018-2021 County Health Rankings data at the county level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Pregnancy-associated deaths were defined as deaths during pregnancy or within 1 year of pregnancy termination. This study focused on unintentional drug overdoses or drug overdoses with undetermined intent involving the most common psychotropic drugs of misuse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2018 to 2021, across the pregnancy-postpartum continuum, pregnancy-associated overdose mortality ratios consistently increased among women aged 10 to 44 years. Mortality ratio more than tripled among pregnant and postpartum women aged 35 to 44 years from 4.9 (95% CI, 3.0-8.0) per 100\u202f000 mothers aged 35 to 44 years with a live birth in January to June 2018 to 15.8 (95% CI, 12.3-20.4) in July to December 2021 (average semiannual percentage changes, 15.9; 95% CI, 8.7-23.6;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Compared with pregnant obstetric decedents, pregnant overdose decedents had increased odds of being aged 10 to 34 years (75.4% vs 59.5%; range of odds ratios [ORs], 1.8 [95% CI, 1.3-2.5] for ages 10 to 24 years to 2.2 [95% CI, 1.7-2.8] for ages 25 to 34 years), being non\u2013college graduates (72.1% vs 59.4%; range of ORs, 2.7 [95% CI, 1.7-4.3] for those with some college education to 3.9 [95% CI, 2.4-6.1] for those with less than high school education), being unmarried (88.0% vs 62.1%; OR, 4.5; 95% CI, 3.7-6.0), and dying in nonhome, non\u2013health care settings (25.9% vs 4.5%; OR, 2.5; 95% CI, 1.8-3.6) and were associated with decreased odds of dying in health care settings (34.7% vs 77.6%; range of ORs, 0.1 [95% CI, 0.1-0.1] for those who died in hospital inpatient settings to 0.4 [95% CI, 0.3-0.6] for those who died in hospital outpatient\/emergency room settings).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yoi230089-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>From 2018 to 2021, the mortality ratio more than tripled among pregnant and postpartum women aged 35 to 44 years, consistent with increases in overdose mortality across US populations. Most pregnancy-associated overdose deaths occurred outside health care settings, indicating the need for strengthening community outreach and maternal medical support. To reduce pregnancy-associated overdose mortality, evidence-based interventions are urgently needed at individual, health care, local, and national levels, along with nonpunitive approaches incentivizing pregnant and postpartum women to seek substance use disorder treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2023.4523","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:35:50Z","timestamp":1700652950000},"page":"270","source":"Crossref","is-referenced-by-count":123,"title":["Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic"],"prefix":"10.1001","volume":"81","author":[{"given":"Beth","family":"Han","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson M.","family":"Compton","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Einstein","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerald","family":"Elder","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"yoi230089r1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/AOG.0000000000004649","article-title":"Pregnancy-associated deaths due to drugs, suicide, and homicide in the United States, 2010-2019.","volume":"139","author":"Margerison","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"21","key":"yoi230089r2","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1001\/jama.2022.17045","article-title":"US trends in drug overdose mortality among pregnant and postpartum persons, 2017-2020.","volume":"328","author":"Bruzelius","year":"2022","journal-title":"JAMA"},{"issue":"16","key":"yoi230089r3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1001\/jama.2021.13971","article-title":"Trends in mortality among pregnant and recently pregnant women in the US, 2015-2019.","volume":"326","author":"Howard","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"yoi230089r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54287","article-title":"Changes in pregnancy-associated deaths in the US during the COVID-19 pandemic in 2020.","volume":"6","author":"Margerison","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"yoi230089r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.32314","article-title":"Racial and ethnic disparities in drug overdose deaths in the US during the COVID-19 pandemic.","volume":"5","author":"Han","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"yoi230089r6","doi-asserted-by":"publisher","first-page":"489.e1","DOI":"10.1016\/j.ajog.2020.02.020","article-title":"Pregnancy-related mortality in the United States, 2003-2016: age, race, and place of death.","volume":"222","author":"Burgess","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"yoi230089r7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21106\/ijma.V6.N2","article-title":"Social determinants of health in the United States: addressing major health inequality trends for the nation, 1935-2016.","volume":"6","author":"Singh","year":"2017","journal-title":"Int J MCH AIDS"},{"issue":"7","key":"yoi230089r8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2105\/AJPH.93.7.1137","article-title":"Area deprivation and widening inequalities in US mortality, 1969-1998.","volume":"93","author":"Singh","year":"2003","journal-title":"Am J Public Health"},{"issue":"1","key":"yoi230089r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227966","article-title":"Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the Mortality Disparities in American Communities Study (MDAC).","volume":"15","author":"Altekruse","year":"2020","journal-title":"PLoS One"},{"issue":"29","key":"yoi230089r11","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital Signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics \u2014 25 states and the District of Columbia, 2019\u20132020.","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"yoi230089r13","first-page":"1","article-title":"Maternal mortality in the United States: Changes in coding, publication, and data release, 2018.","volume":"69","author":"Hoyert","year":"2020","journal-title":"Natl Vital Stat Rep"},{"issue":"158","key":"yoi230089r16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference.","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"yoi230089r17","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.","volume":"7","author":"Irvine","year":"2022","journal-title":"Lancet Public Health"},{"issue":"3","key":"yoi230089r19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","article-title":"Naloxone and buprenorphine prescribing following US emergency department visits for suspected opioid overdose: August 2019 to April 2021.","volume":"79","author":"Chua","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"1","key":"yoi230089r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51856","article-title":"Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic.","volume":"6","author":"Tanz","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"8","key":"yoi230089r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021.","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"yoi230089r22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ajad.v32.5","article-title":"Opioid use disorder at delivery hospitalization in the United States: 2012-2016.","volume":"32","author":"Malhotra","year":"2023","journal-title":"Am J Addict"},{"issue":"4","key":"yoi230089r23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10995-020-03110-2","article-title":"The government\u2019s involvement in prenatal drug testing may be toxic.","volume":"26","author":"Nguemeni Tiako","year":"2022","journal-title":"Matern Child Health J"},{"key":"yoi230089r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108677","article-title":"Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio.","volume":"222","author":"Syvertsen","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"yoi230089r25","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s10995-020-03006-1","article-title":"Secrecy versus disclosure: women with substance use disorders share experiences in help seeking during pregnancy.","volume":"24","author":"Paris","year":"2020","journal-title":"Matern Child Health J"},{"issue":"3","key":"yoi230089r26","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1097\/ADM.0000000000000909","article-title":"Differential gateways, facilitators, and barriers to substance use disorder treatment for pregnant women and mothers: a scoping systematic review.","volume":"16","author":"Choi","year":"2022","journal-title":"J Addict Med"},{"issue":"3","key":"yoi230089r27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/hsc.v29.3","article-title":"Examining barriers to harm reduction and child welfare services for pregnant women and mothers who use substances using a stigma action framework.","volume":"29","author":"Wolfson","year":"2021","journal-title":"Health Soc Care Community"},{"issue":"2","key":"yoi230089r28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jmwh.v66.2","article-title":"The lived experience of postpartum women attending outpatient substance treatment for opioid or heroin use.","volume":"66","author":"Proulx","year":"2021","journal-title":"J Midwifery Womens Health"},{"issue":"5","key":"yoi230089r29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ajad.v32.5","article-title":"Survey of stigma across healthcare workers in an urban, academic medical center regarding perinatal patients using opioids.","volume":"32","author":"Braverman","year":"2023","journal-title":"Am J Addict"},{"issue":"6","key":"yoi230089r30","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/AOG.0000000000001695","article-title":"Maternal deaths from suicide and overdose in Colorado, 2004-2012.","volume":"128","author":"Metz","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"yoi230089r31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1176\/appi.ajp.2020.20020154","article-title":"Contraception for women with psychiatric disorders.","volume":"178","author":"McCloskey","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"3","key":"yoi230089r32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.whi.2020.01.005","article-title":"Adoption of Medicaid expansion is associated with lower maternal mortality.","volume":"30","author":"Eliason","year":"2020","journal-title":"Womens Health Issues"},{"issue":"1","key":"yoi230089r33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1377\/hlthaff.2021.01150","article-title":"The ACA Medicaid expansion and perinatal insurance, health care use, and health outcomes: a systematic review.","volume":"41","author":"Bellerose","year":"2022","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"yoi230089r34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.whi.2017.10.011","article-title":"Federal and state policy efforts to address maternal opioid misuse: gaps and challenges.","volume":"28","author":"Saunders","year":"2018","journal-title":"Womens Health Issues"},{"issue":"1","key":"yoi230089r35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/08897077.2021.1949664","article-title":"Disparities in receipt of medications for opioid use disorder among pregnant women.","volume":"43","author":"Henkhaus","year":"2022","journal-title":"Subst Abus"},{"issue":"6","key":"yoi230089r36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1023\/A:1022266726892","article-title":"Ethnicity and social support during pregnancy.","volume":"27","author":"Sagrestano","year":"1999","journal-title":"Am J Community Psychol"},{"issue":"1","key":"yoi230089r37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53280","article-title":"Evaluation of all-cause and cause-specific mortality by race and ethnicity among pregnant and recently pregnant women in the US, 2019 to 2020.","volume":"6","author":"Howard","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"35","key":"yoi230089r39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.15585\/mmwr.mm6835a3","article-title":"Racial\/ethnic disparities in pregnancy-related deaths\u2014United States, 2007-2016.","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"yoi230089r40","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2105\/AJPH.2021.306375","article-title":"Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016\u20132017.","volume":"111","author":"MacDorman","year":"2021","journal-title":"Am J Public Health"},{"issue":"8","key":"yoi230089r41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jama.2022.1190","article-title":"Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications.","volume":"327","author":"Metz","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"yoi230089r42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21106\/ijma.V10.N1","article-title":"Trends and social inequalities in maternal mortality in the United States, 1969-2018.","volume":"10","author":"Singh","year":"2021","journal-title":"Int J MCH AIDS"},{"issue":"5","key":"yoi230089r43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.amepre.2018.01.040","article-title":"Factors associated with county-level differences in U.S. drug-related mortality rates.","volume":"54","author":"Monnat","year":"2018","journal-title":"Am J Prev Med"},{"issue":"1","key":"yoi230089r44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10550887.2010.531665","article-title":"American Indians\/Alaska Natives and substance abuse treatment outcomes: positive signs and continuing challenges.","volume":"30","author":"Dickerson","year":"2011","journal-title":"J Addict Dis"},{"issue":"3","key":"yoi230089r45","doi-asserted-by":"publisher","first-page":"379.e1","DOI":"10.1016\/j.ajog.2015.05.008","article-title":"Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy.","volume":"213","author":"Hameed","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"yoi230089r46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","article-title":"Reducing disparities in severe maternal morbidity and mortality.","volume":"61","author":"Howell","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"yoi230089r47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/AOG.0000000000004224","article-title":"Racial and ethnic disparities in reproductive health services and outcomes, 2020.","volume":"137","author":"Sutton","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"11","key":"yoi230089r48","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","article-title":"Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women.","volume":"2","author":"Irizarry","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"3","key":"yoi230089r49","doi-asserted-by":"publisher","first-page":"269.e1","DOI":"10.1016\/j.ajog.2019.10.005","article-title":"Pregnant? validity of the pregnancy checkbox on death certificates in four states, and characteristics associated with pregnancy checkbox errors.","volume":"222","author":"Catalano","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"yoi230089r9","unstructured":"Association of American Medical Colleges. Labor pains: the OB-GYN shortage. Accessed on March 7, 2023. https:\/\/www.aamc.org\/news-insights\/labor-pains-ob-gyn-shortage"},{"key":"yoi230089r12","unstructured":"Osterman? MJK, Hamilton? BE, Martin? JA, Driscoll? AK, Valenzuela? CP. Births: final data for 2021. Accessed May 1, 2023. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr72\/nvsr72-01.pdf"},{"key":"yoi230089r14","unstructured":"US Health Resources and Services Administration. Area Health Resources Files. Accessed on March 8, 2023. https:\/\/data.hrsa.gov\/topics\/health-workforce\/ahrf"},{"key":"yoi230089r15","unstructured":"University of Wisconsin Population Health Institute. Rankings data & documentation. Accessed on March 8, 2023. https:\/\/www.countyhealthrankings.org\/explore-health-rankings\/rankings-data-documentation"},{"key":"yoi230089r18","unstructured":"US Food & Drug Administration. FDA approves first over-the-counter naloxone nasal spray. Accessed on August 16, 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray"},{"key":"yoi230089r38","unstructured":"Bianchi? DW, Clayton? JA, Zenk? SN. Addressing inequities to IMPROVE maternal health for all. Accessed on April 23, 2023. https:\/\/www.nichd.nih.gov\/about\/org\/od\/directors_corner\/maternal-health-disparities-april2023"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2811811\/jamapsychiatry_han_2023_oi_230089_1709150844.35332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T11:01:49Z","timestamp":1709722909000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2811811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.4523","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}